Key facts
- It has raised $13.8M; the latest was Later Stage VC ($13.8M) in Feb 2025.
- Notable investors include Lapam Capital, Shanghai Healthcare Capital, Shanghai Shangshi Capital Management, Zeyue Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Stedical Scientific
- ·The full record, as it builds
Funding rounds
No funding rounds for Stedical Scientific are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Stedical Scientific
Provider of biosynthetic membrane designed for health services. The company's products mainly focus on biosynthetic membrane repair materials, which can be applied in the fields of wound repair, surgery, orthopedic trauma, neurological, cardiovascular, and other fields, providing customers with reliable and efficient treatment plans.
- Sector
- Healthcare
- HQ
- Carlsbad, CA, United States
- Founded
- 2019
- Employees
- 10
- Website
- stedical.com/
- Ownership
- Privately Held (backing)
Stedical Scientific doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Stedical Scientific shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Stedical Scientific in its N-PORT filings yet. We sweep new filings monthly.